Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Mar;99(11):e19506.
doi: 10.1097/MD.0000000000019506.

Male axillary accessory breast cancer: A case report

Affiliations
Case Reports

Male axillary accessory breast cancer: A case report

Minglei Bi et al. Medicine (Baltimore). 2020 Mar.

Abstract

Rationale: Accessory breast cancer is extremely rare among all cancerous diseases, especially in male patients. There were only few male axillary accessory breast cancer cases that have been reported in scientific literatures so far. Hereby, we would like to discuss a case of male axillary accessory breast cancer found in our hospital.

Patient concerns: We report a male senile patient suffering from a painful, enlarged, and hardened right axillary mass for more than 20 years. He came for further treatments due to progressive growth of the mass for 11 months with bloody ulceration for more than 1 month.

Diagnosis: Pathological examination manifested a grade II infiltrating ductal carcinoma derived from the accessory mammary gland (right axilla), with invasion of local skin. Immunohistochemical examination result: estrogen receptor (++) 90%, progesterone receptor (+++) 100%, human epidermal growth factor receptor-2 (1+), ki67 (20% positive), prostate specific antigen (-), caudal-related homeobox-2 (-), thyroid transcription factor-1 (-), Synaptophysin (+), NapsinA (1), and CK7 (-).

Interventions: Modified radical mastectomy and axillary lymph nodes clearance were performed on the accessary breast cancer under general anesthesia. Postoperatively, endocrine therapy was provided for the patient, orally-taken Letrozole was recommended for the rest of the patient's life.

Outcomes: The patient recovered uneventfully and was discharged 3 days after the operation. The patient continued to take Letrozole orally regularly at home and no signs of recurrence were observed.

Conclusion: Axillary accessory breast cancer in males is extremely rare, with no conspicuous and typical clinical presentations, which leads to inevitable neglect by clinicians. Therefore, there is significant necessity for clinicians to be cautious with this type of disease.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to disclose.

Figures

Figure 1
Figure 1
The cauliflower-like mass on the right axilla, which is 2.5 cm × 2.4 cm in size, 1.0 cm above the skin surface. The boundary is unclear, the shape is irregular, and the mass is immovable.
Figure 2
Figure 2
Pathological examination result (HE ×100) and pathological examination result (HE ×400). The resected tissue showed invasive growth. The tumor cell nuclei are deep stained and characterized by heteromorphism and caryocinesia. HE = hematoxylin and eosin.
Figure 3
Figure 3
Pathological examination result (HE ×100) and pathological examination result (HE ×400). The resected tissue showed invasive growth. The tumor cell nuclei are deep stained and characterized by heteromorphism and caryocinesia. HE = hematoxylin and eosin.
Figure 4
Figure 4
The operating surgeon removes the lymph nodes sequentially and arrests the bleeding thoroughly.
Figure 5
Figure 5
The operating surgeon removes the cauliflower-like mass in the right axilla and the accessory mammary gland completely.

Similar articles

Cited by

References

    1. Khanna S, Mishra SP, Kumar S, et al. Carcinoma in accessory axillary breast. BMJ Case Rep 2015;bcr2015210944.doi: 10.1136/bcr-2015-210944. - PMC - PubMed
    1. Gutermuth J, Audring H, Voit C, et al. Primary carcinoma of ectopic axillary breast tissue. J Eur Acad Dermatol Venereol 2006;20:217–21. - PubMed
    1. Fentiman IS, Fourquet A, Hortobagyi GN. Male breast cancer. Lancet 2006;367:595–604. - PubMed
    1. Bi L, Li J, Shi Z, et al. Male accessory breast cancer successfully treated with endocrine therapy: a case report. Oncol Lett 2015;10:2495–8. - PMC - PubMed
    1. Zhong GB, Ye XQ, Liu JL, et al. Male accessory breast cancer on the abdominal wall: a case report and literature review. Oncology Targets Ther 2018;11:6625–31. - PMC - PubMed

Publication types

MeSH terms